CYCLERION THERAPEUTICS, INC. Income Tax Expense
CYCLERION THERAPEUTICS, INC. (CYCN) reported Income Tax Expense of $0 for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-07-22.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-22
- CYCLERION THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2019-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2019-09-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2019-06-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2019-03-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2023 was $0.00.
- CYCLERION THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2022 was $0.00.
- CYCLERION THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2021 was $0.00.
- CYCLERION THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2020 was $0.00.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 S-4/A · filed 2026-07-22 | |||
| 2024-12-31 | $0.00 S-4/A · filed 2026-07-22 | |||
| 2023-12-31 | $0.00 10-K/A · filed 2025-11-12 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-05 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-22 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | $0.00 10-K · filed 2020-03-12 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | $0.00 derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | $0.00 derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | $0.00 10-K · filed 2020-03-12 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |